棲霞建設(600533.SH):擬出資5億元與迅燕建設共設南京星燕
格隆匯8月12日丨棲霞建設(600533.SH)公佈,為進一步貫徹公司以房地產為主業的發展戰略、分散經營風險,公司擬與南京迅燕建設有限公司(簡稱“迅燕建設”)共同出資設立南京星燕房地產開發有限公司(簡稱“南京星燕”),註冊資本5.0億元人民幣(認繳)。公司的持股比例為60%;迅燕建設的持股比例為40%;南京星燕為公司的控股子公司。南京星燕設立後,將作為G33號地塊的開發主體,承擔對該地塊的項目開發、建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.